Genome-Wide Association Study and Gene Expression Analysis Identifies CD84 as a Predictor of Response to Etanercept Therapy in Rheumatoid Arthritis
暂无分享,去创建一个
Jing Cui | Philip L. De Jager | Barbara E. Stranger | Henk-Jan Guchelaar | Larry W. Moreland | Robert M. Plenge | John D. Isaacs | Yukinori Okada | Manik Kuchroo | Towfique Raj | Soumya Raychaudhuri | Peter K. Gregersen | Elizabeth W. Karlson | Gosia Trynka | Namrata Gupta | João Eurico Fonseca | Marieke J. H. Coenen | Anne Barton | Hisashi Yamanaka | Masa Umicevic Mirkov | Fumihiko Matsuda | S. Louis Bridges | Michael E. Weinblatt | Nancy A. Shadick | Tsuneyo Mimori | Robert P. Kimberly | Xavier Mariette | Lindsey A. Criswell | P. Gregersen | Y. Okada | A. Barton | B. Stranger | S. Raychaudhuri | C. Allaart | E. Stahl | T. Raj | E. Karlson | R. Plenge | M. A. van de Laar | P. Tak | L. Criswell | N. Gupta | J. Isaacs | Anthony G. Wilson | M. Weinblatt | N. Shadick | A. Morgan | G. Trynka | C. Terao | K. Ikari | K. Ohmura | D. Diogo | J. Cui | M. Coenen | H. Guchelaar | T. Huizinga | X. Mariette | S. L. Bridges | R. Toes | N. de Vries | L. Moreland | A. Taniguchi | L. Padyukov | H. Yamanaka | T. Mimori | S. Momohara | F. Matsuda | M. Doorenspleet | R. Kimberly | S. Saevarsdottir | H. Canhão | P. Riel | Manik Kuchroo | J. Crusius | J. Fonseca | J. Askling | G. Wolbink | K. Hyrich | I. E. van der Horst-Bruinsma | M. Herenius | I. E. Horst-Bruinsma | N. Vries | Ann W. Morgan | Chikashi Terao | Katsunori Ikari | Koichiro Ohmura | Leonid Padyukov | Atsuo Taniguchi | Shigeki Momohara | Saedis Saevarsdottir | C. Miceli | Johan Askling | Gert Jan Wolbink | Niek de Vries | Marieke E. Doorenspleet | Eli A. Stahl | Corinne Miceli | Dorothee Diogo | Maša Umiċeviċ Mirkov | Helena Canhao | Sara Wedrén | Kimme L. Hyrich | Marieke Herenius | Paul-Peter Tak | J. Bart A. Crusius | Irene E. van der Horst-Bruinsma | Piet L. C. M. van Riel | Mart van de Laar | Cornelia F. Allaart | Tom W. J. Huizinga | Rene E. M. Toes | M. D. Laar | S. Wedrén | R. Toes | A. Wilson | P. L. Jager | M. U. Mirkov | A. Barton | Larry W. Moreland | P. Gregersen | J. Isaacs | Gert‐Jan Wolbink | Barbara E. Stranger | P. D. de Jager | Eli A. Stahl | P. L. van Riel | A. G. Wilson | A. Morgan | Robert P. Kimberly | Manik Kuchroo | Tom W J Huizinga | S. Bridges | J. E. Fonseca | Elizabeth W. Karlson | Tom W. J. Huizinga | Gert-Jan Wolbink | T. W. Huizinga | A. W. Morgan
[1] Anbupalam Thalamuthu,et al. TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study. , 2007, The New England journal of medicine.
[2] L. Wasserman,et al. Genomic control, a new approach to genetic-based association studies. , 2001, Theoretical population biology.
[3] Manolis Kellis,et al. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants , 2011, Nucleic Acids Res..
[4] B. Franke,et al. Genetic Variants in Toll-Like Receptors Are Not Associated with Rheumatoid Arthritis Susceptibility or Anti-Tumour Necrosis Factor Treatment Outcome , 2010, PloS one.
[5] Hideo Tanaka,et al. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population , 2012, Nature Genetics.
[6] Ludwig Kappos,et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.
[7] Manuel A. R. Ferreira,et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. , 2008, Human molecular genetics.
[8] C. Werning. [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.
[9] A. Barton,et al. Genome-Wide Association Study of Genetic Predictors of Anti–Tumor Necrosis Factor Treatment Efficacy in Rheumatoid Arthritis Identifies Associations with Polymorphisms at Seven Loci , 2011, Arthritis and rheumatism.
[10] Pablo Engel,et al. CD84 Functions as a Homophilic Adhesion Molecule and Enhances IFN-γ Secretion: Adhesion Is Mediated by Ig-Like Domain 11 , 2001, The Journal of Immunology.
[11] A. Barton,et al. Replication of Association of the PTPRC Gene With Response to Anti–Tumor Necrosis Factor Therapy in a Large UK Cohort , 2012, Arthritis and rheumatism.
[12] Manuel A. R. Ferreira,et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.
[13] S. Batzoglou,et al. Distribution and intensity of constraint in mammalian genomic sequence. , 2005, Genome research.
[14] A. Koch. The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.
[15] M. Prevoo,et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. , 1996, Arthritis and rheumatism.
[16] P. Donnelly,et al. A new multipoint method for genome-wide association studies by imputation of genotypes , 2007, Nature Genetics.
[17] M. Prevoo,et al. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. , 1995, Arthritis and rheumatism.
[18] P. Ravaud,et al. A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis , 2007, Annals of the rheumatic diseases.
[19] Timothy J. Durham,et al. "Systematic" , 1966, Comput. J..
[20] G. Ginsburg,et al. Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. , 2007, The Journal of rheumatology.
[21] Peter Kraft,et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis , 2012, Nature Genetics.
[22] Leopold Parts,et al. A Bayesian Framework to Account for Complex Non-Genetic Factors in Gene Expression Levels Greatly Increases Power in eQTL Studies , 2010, PLoS Comput. Biol..
[23] A. Barton,et al. Genetic and genomic predictors of anti-TNF response. , 2011, Pharmacogenomics.
[24] J. Dahlerup,et al. The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures. , 2003, Cytokine.
[25] P. Jüni,et al. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors. , 2005, Rheumatology.
[26] B. Franke,et al. The tumour necrosis factor receptor superfamily member 1b 676T>G polymorphism in relation to response to infliximab and adalimumab treatment and disease severity in rheumatoid arthritis , 2008, Annals of the rheumatic diseases.
[27] Wentian Li,et al. Genome-Wide Association Scan Identifies Candidate Polymorphisms Associated with Differential Response to Anti-TNF Treatment in Rheumatoid Arthritis , 2008, Molecular medicine.
[28] H. Canhão,et al. Reuma.pt - the rheumatic diseases portuguese register. , 2011, Acta reumatologica portuguesa.
[29] S. Tangye,et al. Functional Requirements for Interactions Between CD84 and Src Homology 2 Domain-Containing Proteins and Their Contribution to Human T Cell Activation 1 , 2003, The Journal of Immunology.
[30] L. Padyukov,et al. Genetic markers for the efficacy of tumour necrosis factor blocking therapy in rheumatoid arthritis , 2003, Annals of the rheumatic diseases.
[31] P. Gregersen,et al. Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy. , 2010, Arthritis and rheumatism.
[32] Susan A Gauthier,et al. A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study. , 2006, Autoimmunity reviews.
[33] B. Scallon,et al. Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. , 1995, Cytokine.
[34] Jing Cui,et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci , 2010, Nature Genetics.
[35] P. Gregersen,et al. Peripheral blood gene expression profiling in rheumatoid arthritis , 2005, Genes and Immunity.
[36] A. Silman,et al. The British Society for Rheumatology Biologics Register , 2005, Annals of the rheumatic diseases.
[37] K. Bendtzen,et al. TNF and LT binding capacities in the plasma of arthritis patients: effect of etanercept treatment in juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.
[38] L. Klareskog,et al. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report. , 2005, Arthritis and rheumatism.
[39] D. Reich,et al. Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.